U.S. FDA nominee moves to untangle potential conflicts of interest

(Reuters) - Dr. Scott Gottlieb, President Donald Trump's nominee to lead the U.S. Food and Drug Administration, has outlined measures he would take to untangle his ties to the pharmaceutical industry if confirmed by the Senate.